In conclusion, our study adds valuable brush strokes to the canvas of HCC immunotherapy, highlighting the roles of COMMD3-BMI1 and Dephospho-CoA in this intricate tableau. This evidence concerns the gene BMI1 and hepatocellular carcinoma.